alpha-突触核蛋白与 LRRK2：共犯关系。
alpha-synuclein and LRRK2: partners in crime.
机构信息
Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, USA.
出版信息
Neuron. 2009 Dec 24;64(6):771-3. doi: 10.1016/j.neuron.2009.12.017.
Abstract
In this issue of Neuron, Lin et al. report that LRRK2 modulates age-related neurodegeneration caused by overexpression of alpha-synuclein in the forebrain of transgenic mice. Overexpression of LRRK2 accelerates the progression of alpha-synuclein-mediated neuropathological changes, whereas deletion of LRRK2 alleviates these alterations. The results reveal an interesting interaction between alpha-synuclein and LRRK2, two gene products linked to dominantly inherited Parkinson's disease.
摘要
在本期《神经元》杂志中，Lin 等人报告称，LRRK2 调节了在转基因小鼠前脑中过表达 α-突触核蛋白引起的与年龄相关的神经退行性变。LRRK2 的过表达加速了 α-突触核蛋白介导的神经病理变化的进展，而 LRRK2 的缺失则减轻了这些改变。这些结果揭示了α-突触核蛋白和 LRRK2 之间的有趣相互作用，这两种基因产物与常染色体显性遗传帕金森病有关。
相似文献
1
alpha-synuclein and LRRK2: partners in crime.alpha-突触核蛋白与 LRRK2：共犯关系。
Neuron. 2009 Dec 24;64(6):771-3. doi: 10.1016/j.neuron.2009.12.017.
2
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.富含亮氨酸重复激酶 2 调节帕金森病相关突变型 α-突触核蛋白诱导的神经病理学进展。
Neuron. 2009 Dec 24;64(6):807-27. doi: 10.1016/j.neuron.2009.11.006.
3
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration.富含亮氨酸重复激酶2（LRRK2）的药理抑制作用可减轻α-突触核蛋白基因诱导的神经退行性变。
J Biol Chem. 2015 Aug 7;290(32):19433-44. doi: 10.1074/jbc.M115.660001. Epub 2015 Jun 15.
4
The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.LRRK2 与 α-突触核蛋白在帕金森病中的不寻常伙伴关系。
Eur J Neurosci. 2019 Feb;49(3):339-363. doi: 10.1111/ejn.14182. Epub 2018 Oct 24.
5
Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.帕金森病中LRRK2与α-突触核蛋白的相互作用
Adv Neurobiol. 2017;14:209-226. doi: 10.1007/978-3-319-49969-7_11.
6
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?富含亮氨酸重复序列激酶2使脑微管蛋白β亚型磷酸化并调节微管稳定性——这是帕金森病神经退行性变的一个交汇点？
J Neurochem. 2009 Sep;110(5):1514-22. doi: 10.1111/j.1471-4159.2009.06235.x. Epub 2009 Jun 22.
7
Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications.帕金森病的 LRRK2 基因突变模型：解析致病途径并探索临床应用。
Mov Disord. 2011 Jul;26(8):1386-97. doi: 10.1002/mds.23737. Epub 2011 Apr 29.
8
LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons.LRRK2 活性不会显著改变原代神经元中的 α-突触核蛋白病理。
Acta Neuropathol Commun. 2018 May 31;6(1):45. doi: 10.1186/s40478-018-0550-0.
9
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models.LRRK2 与帕金森病大脑中α-突触核蛋白的相互作用及在细胞模型中的作用。
J Mol Med (Berl). 2013 Apr;91(4):513-22. doi: 10.1007/s00109-012-0984-y. Epub 2012 Nov 27.
10
The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.LRRK2 G2019S 突变是导致阿什肯纳兹犹太人帕金森病的原因。
J Neural Transm (Vienna). 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0.
引用本文的文献
1
G2019S Mutation Enhances MPP-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons.G2019S突变增强了MPP诱导的人诱导多能干细胞分化的多巴胺能神经元的炎症反应。
Front Neurosci. 2022 Jul 6;16:947927. doi: 10.3389/fnins.2022.947927. eCollection 2022.
2
Studying the effect of alpha-synuclein and Parkinson's disease linked mutants on inter pathway connectivities.研究α-突触核蛋白和帕金森病相关突变体对通路间连接的影响。
Sci Rep. 2021 Aug 11;11(1):16365. doi: 10.1038/s41598-021-95889-5.
3
Mouse Genetic Models of Human Brain Disorders.人类脑部疾病的小鼠遗传模型
Front Genet. 2016 Mar 23;7:40. doi: 10.3389/fgene.2016.00040. eCollection 2016.
4
The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling.LRRK2抑制剂GSK2578215A在SH-SY5Y细胞中诱导保护性自噬：动力相关蛋白1介导的线粒体分裂和线粒体源性活性氧信号的参与
Cell Death Dis. 2014 Aug 14;5(8):e1368. doi: 10.1038/cddis.2014.320.
5
Genetics and genomics of Parkinson's disease.帕金森病的遗传学和基因组学。
Genome Med. 2014 Jun 30;6(6):48. doi: 10.1186/gm566. eCollection 2014.
6
Pax6 interactions with chromatin and identification of its novel direct target genes in lens and forebrain.Pax6 与染色质的相互作用及其在晶状体和前脑的新的直接靶基因的鉴定。
PLoS One. 2013;8(1):e54507. doi: 10.1371/journal.pone.0054507. Epub 2013 Jan 14.
7
Animal models of Parkinson's disease: vertebrate genetics.帕金森病动物模型：脊椎动物遗传学。
Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a009324. doi: 10.1101/cshperspect.a009324.
8
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.LRRK2 G2019S 突变通过激活 MEK/ERK 通路加剧基础自噬。
Cell Mol Life Sci. 2013 Jan;70(1):121-36. doi: 10.1007/s00018-012-1061-y. Epub 2012 Jul 8.
9
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures.帕金森病相关的 LRRK2 在循环和组织免疫细胞中表达，并在识别微生物结构后上调。
J Neural Transm (Vienna). 2011 May;118(5):795-808. doi: 10.1007/s00702-011-0653-2. Epub 2011 May 7.
10
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.基因-环境相互作用：揭开帕金森病之谜的关键。
Prog Neurobiol. 2011 Jun;94(1):1-19. doi: 10.1016/j.pneurobio.2011.03.005. Epub 2011 Mar 23.
本文引用的文献
1
Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson's-disease-related mutant alpha-synuclein.富含亮氨酸重复激酶 2 调节帕金森病相关突变型 α-突触核蛋白诱导的神经病理学进展。
Neuron. 2009 Dec 24;64(6):807-27. doi: 10.1016/j.neuron.2009.11.006.
2
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice.LRRK2基因中的R1441C突变会损害小鼠的多巴胺能神经传递。
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14622-7. doi: 10.1073/pnas.0906334106. Epub 2009 Aug 10.
3
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.突变型LRRK2（R1441G）细菌人工染色体转基因小鼠重现了帕金森病的主要特征。
Nat Neurosci. 2009 Jul;12(7):826-8. doi: 10.1038/nn.2349. Epub 2009 Jun 7.
4
The roles of kinases in familial Parkinson's disease.激酶在家族性帕金森病中的作用。
J Neurosci. 2007 Oct 31;27(44):11865-8. doi: 10.1523/JNEUROSCI.3695-07.2007.
5
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.α-突触核蛋白阻断内质网-高尔基体运输，而Rab1可挽救帕金森病模型中的神经元损失。
Science. 2006 Jul 21;313(5785):324-8. doi: 10.1126/science.1129462. Epub 2006 Jun 22.
6
Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.α-突触核蛋白与CSPα协同作用以预防神经退行性变。
Cell. 2005 Nov 4;123(3):383-96. doi: 10.1016/j.cell.2005.09.028.
7
Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin.导致帕金森病的α-突触核蛋白稳态改变：达旦蛋白的潜在作用
Trends Neurosci. 2005 Aug;28(8):416-21. doi: 10.1016/j.tins.2005.05.009.
8
Mitochondria and dopamine: new insights into recessive parkinsonism.线粒体与多巴胺：对隐性帕金森病的新见解
Neuron. 2004 Aug 5;43(3):301-4. doi: 10.1016/j.neuron.2004.07.012.
9
Golgi fragmentation occurs in the cells with prefibrillar alpha-synuclein aggregates and precedes the formation of fibrillar inclusion.高尔基体碎片化发生在具有原纤维前体α-突触核蛋白聚集体的细胞中，并先于纤维状包涵体的形成。
J Biol Chem. 2002 Dec 13;277(50):48984-92. doi: 10.1074/jbc.M208194200. Epub 2002 Sep 25.
10
Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.携带与家族性帕金森病相关的丙氨酸-53→苏氨酸突变的人α-突触核蛋白在转基因小鼠中导致伴有α-突触核蛋白聚集的神经退行性疾病。
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8968-73. doi: 10.1073/pnas.132197599.
Zotero 插件